PHILLIP BRICK: Open Payments
NPI 1689787459 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 83 payments from 16 companies in 2025. Trend: 2023 $1,186 · 2024 $1,512 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $478 |
| Novo Nordisk Inc | 14 | $222 |
| Lilly USA, LLC | 9 | $157 |
| Amgen Inc. | 14 | $137 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| PFIZER INC. | 3 | $54 |
| Medtronic, Inc. | 2 | $44 |
| Radius Health, Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
Products named: VRAYLAR, MOUNJARO, UBRELVY, Ozempic, Wegovy, QULIPTA, KRYSTEXXA, LEQVIO.
Industry payments across MO — which companies pay providers there.
